How does the postoperative outcome differ in peritoneal surface malignancy after management with CRS and HIPEC + EPIC using Taxol vs. CRS and HIPEC + EPIC using 5-FU?

More Paul F. Dranichnikov's questions See All
Similar questions and discussions